Darabi M, Ani M, Panjehpour M, Rabbani M, Movahedian A, Zarean E (2011). "Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy". Genetic Testing and Molecular Biomarkers. 15 (1–2): 11–15. doi:10.1089/gtmb.2010.0106. PMID21117950.
Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly-Y M, Rudling M, et al. (November 2000). "Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice". Biochemical and Biophysical Research Communications. 278 (3): 640–645. doi:10.1006/bbrc.2000.3827. PMID11095962.
Deng L, Wu T, Chen XY, Xie L, Yang J (October 2012). "Selective estrogen receptor modulators (SERMs) for uterine leiomyomas". The Cochrane Database of Systematic Reviews. 10: CD005287. doi:10.1002/14651858.CD005287.pub4. PMID23076912.
Ascenzi P, Bocedi A, Marino M (August 2006). "Structure-function relationship of estrogen receptor alpha and beta: impact on human health". Molecular Aspects of Medicine. 27 (4): 299–402. doi:10.1016/j.mam.2006.07.001. PMID16914190.
Bourguet W, Germain P, Gronemeyer H (October 2000). "Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications". Trends in Pharmacological Sciences. 21 (10): 381–388. doi:10.1016/S0165-6147(00)01548-0. PMID11050318.
Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR (September 2006). "Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding". Endocrinology. 147 (9): 4132–4150. doi:10.1210/en.2006-0113. PMID16728493.
Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N (July 2005). "Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release". Molecular and Cellular Endocrinology. 239 (1–2): 27–36. doi:10.1016/j.mce.2005.04.008. PMID15950373. S2CID42052008.
Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, et al. (November 2008). "Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness". Fertility and Sterility. 90 (5): 1878–1885. doi:10.1016/j.fertnstert.2007.09.019. hdl:10442/7330. PMID18166184.
Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, et al. (November 2008). "Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness". Fertility and Sterility. 90 (5): 1878–1885. doi:10.1016/j.fertnstert.2007.09.019. hdl:10442/7330. PMID18166184.
Pfeffer U, Fecarotta E, Vidali G (May 1995). "Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells". Cancer Research. 55 (10): 2158–2165. PMID7743517.
Darabi M, Ani M, Panjehpour M, Rabbani M, Movahedian A, Zarean E (2011). "Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy". Genetic Testing and Molecular Biomarkers. 15 (1–2): 11–15. doi:10.1089/gtmb.2010.0106. PMID21117950.
Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly-Y M, Rudling M, et al. (November 2000). "Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice". Biochemical and Biophysical Research Communications. 278 (3): 640–645. doi:10.1006/bbrc.2000.3827. PMID11095962.
Deng L, Wu T, Chen XY, Xie L, Yang J (October 2012). "Selective estrogen receptor modulators (SERMs) for uterine leiomyomas". The Cochrane Database of Systematic Reviews. 10: CD005287. doi:10.1002/14651858.CD005287.pub4. PMID23076912.
Ascenzi P, Bocedi A, Marino M (August 2006). "Structure-function relationship of estrogen receptor alpha and beta: impact on human health". Molecular Aspects of Medicine. 27 (4): 299–402. doi:10.1016/j.mam.2006.07.001. PMID16914190.
Bourguet W, Germain P, Gronemeyer H (October 2000). "Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications". Trends in Pharmacological Sciences. 21 (10): 381–388. doi:10.1016/S0165-6147(00)01548-0. PMID11050318.
Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR (September 2006). "Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding". Endocrinology. 147 (9): 4132–4150. doi:10.1210/en.2006-0113. PMID16728493.
Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N (July 2005). "Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release". Molecular and Cellular Endocrinology. 239 (1–2): 27–36. doi:10.1016/j.mce.2005.04.008. PMID15950373. S2CID42052008.
Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, et al. (November 2008). "Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness". Fertility and Sterility. 90 (5): 1878–1885. doi:10.1016/j.fertnstert.2007.09.019. hdl:10442/7330. PMID18166184.